Phosphodiesterase 5 Inhibitors Enhance Chemotherapy Killing in Gastrointestinal/Genitourinary Cancer Cells

The present studies determined whether clinically relevant phosphodiesterase 5 (PDE5) inhibitors interacted with clinically relevant chemotherapies to kill gastrointestinal/genitourinary cancer cells. In bladder cancer cells, regardless of H-RAS mutational status, at clinically achievable doses, PDE...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Booth, Laurence, Roberts, Jane L., Cruickshanks, Nichola, Conley, Adam, Durrant, David E., Das, Anindita, Fisher, Paul B., Kukreja, Rakesh C., Grant, Steven, Poklepovic, Andrew, Dent, Paul
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: The American Society for Pharmacology and Experimental Therapeutics 2014
Konular:
Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3935155/
https://ncbi.nlm.nih.gov/pubmed/24353313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1124/mol.113.090043
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller